pharmanaming

GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic...

Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the...

Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace....

New drug names aren’t just bizarre—they’re dangerous. What would Don Draper make of Xalkori? Pfizer’s lung cancer drug, released in 2011,...

Street names aside, who comes up with crazy non-words like Zyrtec, Tenofovir and Xeljanz? Say it with me: Xeljanz. OK, at least try and...

It was a brilliant marketing strategy … instead of marketing the fast-acting Nurofen for pain relief as one product effective for a range...

Vivisum has launched Brand Builder, a solution that provides strategic market insight for pharmaceutical brands. Brand Builder combines...

From www.fiercepharma.com Drugmakers, biotechs and their generic rivals are squabbling over the names that will be assigned to...

Ira Levy of Goodwin Procter discusses the FDA regulation for drug names and how companies can reduce their chances of rejection. What is...

The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market. Most brand-name drugs...

From www.theguardian.com What if brand loyalty was actually as serious as life and death? Nick Dutnall looks at how we might trust a...

from www.mmm-online.com Since the birth of branding, and particularly in the advent of the “like,” people have been using brands as a...

Sponsors filing a drug submission must also provide a brand name assessment as part of the drug safety and effectiveness evaluation. The...

Farxiga. Hetlioz. Otezla. Zykadia. No, these are not the names of distant planets visited by the starship Enterprise. They're the brand...

Biogen's ($BIIB) recent change back to its original name - from the decade-old merger name Biogen Idec - made sense in many ways. Along...

Companies are scrambling to get into the immunotherapy market, which experts think could eventually be worth up to £26bn a year in sales....

As we start our column in earnest, we thought we should perhaps state our position, be clear on some boundaries and definitions of what...

Not only is the process of christening a new product a lot trickier than it sounds, the most obvious candidates can be the most perilous....

There’s no question that biosimilars are a revolution in life sciences. The development of these complex medications made from living...

India had exported medicines worth $15.2 billion (about Rs 97,000 crore) in 2014-15, an increase of 5% over the previous year’s figure....